Penumbra, Inc. (PEN)

USD 238.9

(-3.49%)

Gross Profit Summary of Penumbra, Inc.

  • Penumbra, Inc.'s latest annual gross profit in 2023 was 682.64 Million USD , up 27.55% from previous year.
  • Penumbra, Inc.'s latest quarterly gross profit in 2024 Q1 was 178.65 Million USD , down -4.46% from previous quarter.
  • Penumbra, Inc. reported a annual gross profit of 535.2 Million USD in annual gross profit 2022, up 12.58% from previous year.
  • Penumbra, Inc. reported a annual gross profit of 475.38 Million USD in annual gross profit 2021, up 40.57% from previous year.
  • Penumbra, Inc. reported a quarterly gross profit of 200.3 Million USD for 2024 Q3, up 24.92% from previous quarter.
  • Penumbra, Inc. reported a quarterly gross profit of 160.34 Million USD for 2024 Q2, down -10.25% from previous quarter.

Annual Gross Profit Chart of Penumbra, Inc. (2023 - 2012)

Historical Annual Gross Profit of Penumbra, Inc. (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 682.64 Million USD 27.55%
2022 535.2 Million USD 12.58%
2021 475.38 Million USD 40.57%
2020 338.17 Million USD -9.08%
2019 371.96 Million USD 27.15%
2018 292.53 Million USD 34.72%
2017 217.14 Million USD 27.11%
2016 170.82 Million USD 37.7%
2015 124.05 Million USD 49.75%
2014 82.84 Million USD 43.14%
2013 57.87 Million USD 18.2%
2012 48.96 Million USD 0.0%

Peer Gross Profit Comparison of Penumbra, Inc.

Name Gross Profit Gross Profit Difference
Abbott Laboratories 22.13 Billion USD 96.916%
Allurion Technologies Inc. 41.49 Million USD -1545.042%
Artivion, Inc. 229.17 Million USD -197.868%
Avanos Medical, Inc. 379.7 Million USD -79.785%
Butterfly Network, Inc. 16.85 Million USD -3949.852%
Butterfly Network, Inc. 16.85 Million USD -3949.852%
Bio-Rad Laboratories, Inc. 1.43 Billion USD 52.308%
Boston Scientific Corporation 9.89 Billion USD 93.101%
Perspective Therapeutics, Inc. 1.63 Million USD -41677.417%
CONMED Corporation 643.06 Million USD -6.154%
Edwards Lifesciences Corporation 4.62 Billion USD 85.24%
Paragon 28, Inc. 172.79 Million USD -295.069%
Glaukos Corporation 239.13 Million USD -185.462%
Globus Medical, Inc. 1.02 Billion USD 33.094%
Inspire Medical Systems, Inc. 528.22 Million USD -29.234%
Integer Holdings Corporation 418.28 Million USD -63.199%
Medtronic plc 19.45 Billion USD 96.491%
Nevro Corp. 290.06 Million USD -135.345%
Owlet, Inc. 22.58 Million USD -2922.283%
Vicarious Surgical Inc. -1.85 Million USD 36920.011%
Smith & Nephew plc 3.7 Billion USD 81.555%
Sonendo, Inc. 10.72 Million USD -6266.751%
STERIS plc 2.23 Billion USD 69.443%
Stryker Corporation 13.05 Billion USD 94.772%
Vapotherm, Inc. 28.28 Million USD -2313.616%
Zimmer Biomet Holdings, Inc. 5.31 Billion USD 87.145%